US Stock MarketDetailed Quotes

ACRS Aclaris Therapeutics

Watchlist

2.330
+0.130+5.91%

Close Feb 14 16:00 ET

2.320
-0.010-0.43%

Post 20:01 ET

249.35MMarket Cap-4.48P/E (TTM)

Aclaris Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aclaris Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 2.582M	--
--	2024/Q4	-- / 7.041M	--
--	2024/Q3	4.346M / 11.849M	--
--	2024/Q2	2.766M / 1.817M	--
May 7, 2024	2024/Q1	2.398M / 1.929M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 2.582M--

--2024/Q4-- / 7.041M--

--2024/Q34.346M / 11.849M--

--2024/Q22.766M / 1.817M--

May 7, 20242024/Q12.398M / 1.929M--

Unlock Free Earnings Estimates

Open Account

Aclaris Therapeutics Earnings Reports

Aclaris Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 6, 2024 16:34 ET

Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

Nov 6, 2024 07:22 ET

Aclaris Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 7, 2024 22:20 ET

Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

Aug 7, 2024 07:21 ET